| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A Comparative Study of Sex Distribution, Autoimmunity, Blood, and Inflammatory Parameters in Chronic Spontaneous Urticaria with Angioedema and Chronic Histaminergic Angioedema
|
Sabaté-Brescó, Marina
|
|
|
9 |
6 |
p. 2284-2292
|
article
|
| 2 |
A Cost-Effectiveness Analysis of Epinephrine Autoinjector Risk Stratification for Patients with Food Allergy—One Epinephrine Autoinjector or Two?
|
Shaker, Marcus
|
|
|
9 |
6 |
p. 2440-2451.e3
|
article
|
| 3 |
Analysis of spirometry measurements as predictors of aspirin desensitization outcomes
|
Pitlick, Mitchell M.
|
|
|
9 |
6 |
p. 2495-2497.e2
|
article
|
| 4 |
A Paucity of Outcomes
|
Honsinger, Richard W.
|
|
|
9 |
6 |
p. 2342-2343
|
article
|
| 5 |
A Practical Approach to Assist Asthmatics to Lose Weight
|
Kolinsky, Nicholas C.
|
|
|
9 |
6 |
p. 2245-2254
|
article
|
| 6 |
Artificial Intelligence/Machine Learning in Respiratory Medicine and Potential Role in Asthma and COPD Diagnosis
|
Kaplan, Alan
|
|
|
9 |
6 |
p. 2255-2261
|
article
|
| 7 |
Assessing health-related quality of life in children with food allergy and eosinophilic esophagitis
|
Szafron, Vibha
|
|
|
9 |
6 |
p. 2520-2523.e2
|
article
|
| 8 |
Association of step count with PROMIS pediatric health-related quality of life measures in children and adolescents with persistent asthma
|
Hernandez, Michelle L.
|
|
|
9 |
6 |
p. 2492-2494
|
article
|
| 9 |
Asthma may not be a risk factor for severe COVID-19 in children
|
Amat, Flore
|
|
|
9 |
6 |
p. 2478-2479
|
article
|
| 10 |
Biphasic Blue Urticaria
|
Rama, Tiago Azenha
|
|
|
9 |
6 |
p. 2474-2475
|
article
|
| 11 |
CD3−CD4+ Lymphocytic Variant Hypereosinophilic Syndrome: Diagnostic Tools Revisited
|
Carpentier, Caroline
|
|
|
9 |
6 |
p. 2426-2439.e7
|
article
|
| 12 |
Characterization of Asthma Trajectories from Infancy to Young Adulthood
|
Ödling, Maria
|
|
|
9 |
6 |
p. 2368-2376.e3
|
article
|
| 13 |
Chronic Urticaria and Recurrent Angioedema: Clues to the Mimics
|
Peter, Jonathan
|
|
|
9 |
6 |
p. 2220-2228
|
article
|
| 14 |
Circulating blood eosinophils as a biomarker for variable clinical presentation and therapeutic response in patients with chronic pruritus of unknown origin
|
Roh, Youkyung S.
|
|
|
9 |
6 |
p. 2513-2516.e2
|
article
|
| 15 |
CME exam: How to Measure Disease Activity, Impact, and Control in Patients with Recurrent Wheals, Angioedema, or Both
|
|
|
|
9 |
6 |
p. 2158-2159
|
article
|
| 16 |
CME exam: Triggers of Exacerbation in Chronic Urticaria and Recurrent Angioedema—Prevalence and Relevance
|
|
|
|
9 |
6 |
p. 2169
|
article
|
| 17 |
CME exam: What's New in the Treatment of Urticaria and Angioedema
|
|
|
|
9 |
6 |
p. 2185
|
article
|
| 18 |
Community Use of Epinephrine for the Treatment of Anaphylaxis: A Review and Meta-Analysis
|
Miles, Laura May
|
|
|
9 |
6 |
p. 2321-2333
|
article
|
| 19 |
Comparing Antihistamines in Chronic Spontaneous Urticaria: Possible Future Directions
|
Larenas-Linnemann, Désirée
|
|
|
9 |
6 |
p. 2272-2273
|
article
|
| 20 |
Complete remission of eosinophilic esophagitis with multi-aeroallergen subcutaneous immunotherapy: A case report
|
Iglesia, Edward G.A.
|
|
|
9 |
6 |
p. 2517-2519.e2
|
article
|
| 21 |
Continuing Medical Education Calendar
|
|
|
|
9 |
6 |
p. A27-A28
|
article
|
| 22 |
Corrections
|
|
|
|
9 |
6 |
p. 2553
|
article
|
| 23 |
Cover 1
|
|
|
|
9 |
6 |
p. OFC
|
article
|
| 24 |
“COVID Arm”: Very delayed large injection site reactions to mRNA COVID-19 vaccines
|
Ramos, Courtney L.
|
|
|
9 |
6 |
p. 2480-2481
|
article
|
| 25 |
COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)
|
Bonadonna, Patrizia
|
|
|
9 |
6 |
p. 2139-2144
|
article
|
| 26 |
COVID-19 Vaccination in Patients with Reported Allergic Reactions: Updated Evidence and Suggested Approach
|
Banerji, Aleena
|
|
|
9 |
6 |
p. 2135-2138
|
article
|
| 27 |
Current approach to the diagnosis of allergic bronchopulmonary aspergillosis
|
Türk, Murat
|
|
|
9 |
6 |
p. 2546
|
article
|
| 28 |
Delayed hypersensitivity reactions to piperacillin-tazobactam
|
Copaescu, Ana
|
|
|
9 |
6 |
p. 2548
|
article
|
| 29 |
Digital Health Technology in Asthma: A Comprehensive Scoping Review
|
Mosnaim, Giselle
|
|
|
9 |
6 |
p. 2377-2398
|
article
|
| 30 |
Do rural health disparities affect prevalence data in pediatric eosinophilic esophagitis?
|
Sabet, Cameron
|
|
|
9 |
6 |
p. 2549-2551
|
article
|
| 31 |
Duration of chronic spontaneous urticaria remission after omalizumab discontinuation: A long-term observational study
|
Di Bona, Danilo
|
|
|
9 |
6 |
p. 2482-2485.e2
|
article
|
| 32 |
Editorial Board
|
|
|
|
9 |
6 |
p. A23
|
article
|
| 33 |
Efficacy of lanadelumab in acquired angioedema with C1-inhibitor deficiency
|
Belbézier, Aude
|
|
|
9 |
6 |
p. 2490-2491
|
article
|
| 34 |
Erratum
|
|
|
|
9 |
6 |
p. 2553
|
article
|
| 35 |
Estimating COVID-19 Infection and Severity Risks in Patients with Chronic Rhinosinusitis: A Korean Nationwide Cohort Study
|
Lee, Seung Won
|
|
|
9 |
6 |
p. 2262-2271.e2
|
article
|
| 36 |
Fixed drug eruption due to bismuth during Helicobacter pylori eradication therapy
|
Galleani, Celine
|
|
|
9 |
6 |
p. 2503-2504
|
article
|
| 37 |
Heterogeneity of Paucigranulocytic Asthma: A Prospective Cohort Study with Hierarchical Cluster Analysis
|
Deng, Ke
|
|
|
9 |
6 |
p. 2344-2355
|
article
|
| 38 |
Hormonal Effects on Urticaria and Angioedema Conditions
|
Bernstein, Jonathan A.
|
|
|
9 |
6 |
p. 2209-2219
|
article
|
| 39 |
Household Cleaning and Poor Asthma Control Among Elderly Women
|
Dumas, Orianne
|
|
|
9 |
6 |
p. 2358-2365.e4
|
article
|
| 40 |
How important is the second dose of the COVID-19 mRNA vaccine?
|
Liu, Anne Y.
|
|
|
9 |
6 |
p. 2537
|
article
|
| 41 |
How to Measure Disease Activity, Impact, and Control in Patients with Recurrent Wheals, Angioedema, or Both
|
Katelaris, Constance Helen
|
|
|
9 |
6 |
p. 2151-2157
|
article
|
| 42 |
Identifying Subtypes of Paucigranulocytic Asthma: Now There Are 3
|
Thomson, Neil C.
|
|
|
9 |
6 |
p. 2356-2357
|
article
|
| 43 |
IgE-binding and mast cell–activating capacity of the homologue of the major birch pollen allergen and profilin from Cannabis sativa
|
Ebo, Didier G.
|
|
|
9 |
6 |
p. 2509-2512.e3
|
article
|
| 44 |
Impact of Technology-Based Interventions on Patient-Reported Outcomes in Asthma: A Systematic Review
|
Doshi, Hiten
|
|
|
9 |
6 |
p. 2336-2341
|
article
|
| 45 |
Implementing a penicillin allergy delabeling service for the obstetric population
|
Zhang, Bei Yuan
|
|
|
9 |
6 |
p. 2501-2502.e2
|
article
|
| 46 |
Indirect Treatment Comparison of Biologics in Chronic Rhinosinusitis with Nasal Polyps
|
Peters, Anju T.
|
|
|
9 |
6 |
p. 2461-2471.e5
|
article
|
| 47 |
Information for Readers
|
|
|
|
9 |
6 |
p. A24
|
article
|
| 48 |
Management of Hypersensitivity Reactions to Nondextran Iron Products: New Insights Into Predisposing Risk Factors
|
Steveling-Klein, Esther Helen
|
|
|
9 |
6 |
p. 2406-2414.e2
|
article
|
| 49 |
Managing Chronic Urticaria and Recurrent Angioedema Differently with Advancing Age
|
Longhurst, Hilary J.
|
|
|
9 |
6 |
p. 2186-2194
|
article
|
| 50 |
Masquerader of Lip Angioedema After Lip Injection
|
Hsu, Chih-Hsin
|
|
|
9 |
6 |
p. 2472-2473
|
article
|
| 51 |
Multidisciplinary single-center outcomes compared to two-center outcomes for the treatment of aspirin exacerbated respiratory disease
|
Bosso, John V.
|
|
|
9 |
6 |
p. 2498-2500
|
article
|
| 52 |
Multivariate Association of Child Depression and Anxiety with Asthma Outcomes
|
Kulikova, Alexandra
|
|
|
9 |
6 |
p. 2399-2405
|
article
|
| 53 |
Nonirritant concentrations for skin testing with SARS-CoV-2 mRNA vaccine
|
Marcelino, João
|
|
|
9 |
6 |
p. 2476-2477
|
article
|
| 54 |
Original Article Highlights From This Issue
|
|
|
|
9 |
6 |
p. A16-A20
|
article
|
| 55 |
Partnering with Patients and Communities to Improve Prehospital Anaphylaxis Care
|
Shaker, Marcus
|
|
|
9 |
6 |
p. 2334-2335
|
article
|
| 56 |
Patient variability in severity of COVID-19 disease. Main suspect: vascular endothelium
|
Tricarico, Gerardo
|
|
|
9 |
6 |
p. 2540-2541
|
article
|
| 57 |
Peanut allergen reaction thresholds during controlled food challenges in 2 Canadian randomized studies (Canada-ARM1 and PISCES)
|
Chu, Derek K.
|
|
|
9 |
6 |
p. 2524-2526.e2
|
article
|
| 58 |
Practice Notes from the AAAI
|
|
|
|
9 |
6 |
p. A25-A26
|
article
|
| 59 |
Prevalence of Antibiotic Allergy Labels in a Tertiary Referral Center in Belgium
|
Gilissen, Liesbeth
|
|
|
9 |
6 |
p. 2415-2425.e8
|
article
|
| 60 |
Proposal for a new classification of vibratory urticaria/angioedema
|
Pastor-Nieto, María Antonia
|
|
|
9 |
6 |
p. 2542-2543
|
article
|
| 61 |
Protective effects of eosinophils against COVID-19: More than an ACE(2) in the hole?
|
Drake, Matthew G.
|
|
|
9 |
6 |
p. 2539-2540
|
article
|
| 62 |
Randomized Trial of the Efficacy and Safety of Berotralstat (BCX7353) as an Oral Prophylactic Therapy for Hereditary Angioedema: Results of APeX-2 Through 48 Weeks (Part 2)
|
Wedner, H. James
|
|
|
9 |
6 |
p. 2305-2314.e4
|
article
|
| 63 |
Real-World Effectiveness of Anti–IL-5/5R Therapy in Severe Atopic Eosinophilic Asthma with Fungal Sensitization
|
Dhariwal, Jaideep
|
|
|
9 |
6 |
p. 2315-2320.e1
|
article
|
| 64 |
Refractory thoracic conidiobolomycosis treated with mepolizumab immunotherapy
|
Yeoh, Daniel K.
|
|
|
9 |
6 |
p. 2527-2530.e6
|
article
|
| 65 |
Reply to “Current approach to the diagnosis of allergic bronchopulmonary aspergillosis”
|
Muthu, Valliappan
|
|
|
9 |
6 |
p. 2546-2548
|
article
|
| 66 |
Reply to “Delayed hypersensitivity reactions to piperacillin-tazobactam”
|
Gallardo, Alicia
|
|
|
9 |
6 |
p. 2549
|
article
|
| 67 |
Reply to “Do rural health disparities affect prevalence data in pediatric eosinophilic esophagitis?”
|
McGowan, Emily C.
|
|
|
9 |
6 |
p. 2551-2552
|
article
|
| 68 |
Reply to “How important is the second dose of the COVID-19 mRNA vaccine?”
|
Shaker, Marcus S.
|
|
|
9 |
6 |
p. 2537-2539
|
article
|
| 69 |
Reply to “Patient variability in severity of COVID-19 disease. Main suspect: vascular endothelium”
|
Ballow, Mark
|
|
|
9 |
6 |
p. 2541-2542
|
article
|
| 70 |
Reply to “Proposal for a new classification of vibratory urticaria/angioedema”
|
Kulthanan, Kanokvalai
|
|
|
9 |
6 |
p. 2543-2544
|
article
|
| 71 |
Reply to “Protective effects of eosinophils against COVID-19: More than an ACE(2) in the hole?”
|
Ferastraoaru, Denisa
|
|
|
9 |
6 |
p. 2540
|
article
|
| 72 |
Reply to “Thoracic conidiobolomycosis: Invasive or allergic?”
|
Yeoh, Daniel K.
|
|
|
9 |
6 |
p. 2545-2546
|
article
|
| 73 |
School Attendance, Asthma Risk, and COVID-19 in Children
|
Abrams, Elissa M.
|
|
|
9 |
6 |
p. 2145-2150
|
article
|
| 74 |
Successful administration of omalizumab by desensitization protocol following systemic reactions in 12 patients
|
Bernaola, Marta
|
|
|
9 |
6 |
p. 2505-2508.e1
|
article
|
| 75 |
Systemic mastocytosis with an associated hematologic neoplasm complicated by recurrent anaphylaxis: Prompt resolution of anaphylaxis with the addition of avapritinib
|
Kudlaty, Elizabeth
|
|
|
9 |
6 |
p. 2534-2536
|
article
|
| 76 |
Table of Contents
|
|
|
|
9 |
6 |
p. A2, A4, A6, A8-A15
|
article
|
| 77 |
The Diagnostic Workup in Chronic Spontaneous Urticaria—What to Test and Why
|
Metz, Martin
|
|
|
9 |
6 |
p. 2274-2283
|
article
|
| 78 |
The Expanding Spectrum of Mutations in Hereditary Angioedema
|
Veronez, Camila Lopes
|
|
|
9 |
6 |
p. 2229-2234
|
article
|
| 79 |
The Genetic Basis and Clinical Impact of Hereditary Alpha-Tryptasemia
|
Luskin, Kathleen T.
|
|
|
9 |
6 |
p. 2235-2242
|
article
|
| 80 |
The Panorama of Primary Angioedema in the Brazilian Population
|
Veronez, Camila Lopes
|
|
|
9 |
6 |
p. 2293-2304.e5
|
article
|
| 81 |
The Pathogenesis of Chronic Spontaneous Urticaria: The Role of Infiltrating Cells
|
Giménez-Arnau, Ana M.
|
|
|
9 |
6 |
p. 2195-2208
|
article
|
| 82 |
The Psychosocial Burden of Food Allergy Among Adults: A US Population-Based Study
|
Warren, Christopher
|
|
|
9 |
6 |
p. 2452-2460.e3
|
article
|
| 83 |
The Road to Better Urticaria and Angioedema Management
|
Riedl, Marc
|
|
|
9 |
6 |
p. 2243-2244
|
article
|
| 84 |
Thoracic conidiobolomycosis: Invasive or allergic?
|
Muthu, Valliappan
|
|
|
9 |
6 |
p. 2544-2545
|
article
|
| 85 |
Time for Action on Cleaning and Disinfecting Agents
|
Tarlo, Susan M.
|
|
|
9 |
6 |
p. 2366-2367
|
article
|
| 86 |
Tocilizumab treatment in patients with Schnitzler syndrome: An open-label study
|
Bonnekoh, Hanna
|
|
|
9 |
6 |
p. 2486-2489.e4
|
article
|
| 87 |
Triggers of Exacerbation in Chronic Urticaria and Recurrent Angioedema—Prevalence and Relevance
|
Grumach, Anete Sevciovic
|
|
|
9 |
6 |
p. 2160-2168
|
article
|
| 88 |
Use of ruxolitinib to control graft-versus-host–like disease in Omenn syndrome and successfully bridging to HSCT
|
Grasso, Antonio Giacomo
|
|
|
9 |
6 |
p. 2531-2533.e1
|
article
|
| 89 |
What’s New in the Treatment of Urticaria and Angioedema
|
Khan, David A.
|
|
|
9 |
6 |
p. 2170-2184
|
article
|
Journal description